article thumbnail

More Florida Teens Strapping Up, Study Says

Drugs.com

TUESDAY, July 8, 2025 — More Florida teens are roaming the streets packing heat, a new study says.Handgun carrying among Florida middle and high school students increased by 65% between 2002 and 2022, researchers reported July 7 in the journal P.

article thumbnail

Intellia Reports Positive 3-Year Phase 1 Data for Lonvo-z in Hereditary Angioedema

The Pharma Data

The data, which encompass up to 3 years of follow-up after a single infusion of the treatment, were shared in an oral presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, held from June 13–16 in Glasgow, United Kingdom.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Building better brain models for Parkinson’s disease and beyond

Drug Target Review

Meet Professor Jens Christian Schwamborn In 2002, Jens obtained a diploma in Biochemistry from the University of Witten/Herdecke in Germany and in 2005 a PhD in Biology from the University of Muenster in Germany. He worked as a postdoctoral researcher at the Institute for Molecular Biotechnology in Vienna, Austria.

article thumbnail

Gepirone

New Drug Approvals

The FDA rejected approval for gepirone in 2002 and 2004. [5] 1] It is taken orally. [1] 1] Side effects of gepirone include dizziness , nausea , insomnia , abdominal pain , and dyspepsia (indigestion). [1] 1] Gepirone acts as a partial agonist of the serotonin 5-HT 1A receptor. [1] 5] SYN Synthesis Ormaza, V.

FDA
article thumbnail

Panel urges FDA to remove warnings on hormonal menopause therapy

BioPharma Drive: Drug Pricing

The study was stopped early in 2002 after researchers observed an increased risk of breast cancer and heart disease. Those warnings stem from a major study conducted by the Womens Health Initiative , or WHI, which evaluated the use of estrogen plus progestin in postmenopausal women.

article thumbnail

Landiolol

New Drug Approvals

Landiolol was approved for medical use in Japan in 2002, [10] [11] in Canada in November 2023, [1] and in the United States in November 2024. [12] This has a positive impact on the treatment of patients when reduction of heart rate without decrease in arterial blood pressure is desired. [9] 9] It is used as landiolol hydrochloride.

FDA
article thumbnail

LEVALBUTEROL TARTRATE

New Drug Approvals

Through HPLC analysis, the purity is 99.95%, and the isomer content is not detected, as shown in figures 1-4. The total yield of the four-step reaction is 87.5